Bayer Secures Backing For Job Cuts But Not For Break-Up

18 Jan 2024

The German major's works council has agreed to support a significant reduction in managerial jobs but is “vigorously campaigning” to ensure that the firm's three-division structure remains intact.

Bayer AG CEO Bill Anderson's plans for a radical realignment of the company to reduce bureaucracy and increase efficiency have been bolstered by union backing in Germany for major management job cuts, but any proposals to break up its three-pillar structure of pharma, consumer health and crop science will likely meet with considerable opposition.

The Leverkusen-headquartered group has introduced a new operating model called dynamic shared ownership (DSO) worldwide, which Bayer claims will "reduce...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Bristol Appoints AstraZeneca’s Massacesi As Next CMO

25 Jul 2025

• By Jessica Merrill

Chief Medical Officer Samit Hirawat will step down to pursue new career opportunities, the company said.

Deal Watch: Novartis Hopes To Ace Inflammatory Disease With Matchpoint Tie-Up

25 Jul 2025

• By Joseph Haas, Lisa Takagi, and Manas Mishra

Plus deals involving Lilly/Gate Bioscience, Concentra/iTeos, Nicox/Kowa, Ajax/Schrodinger, I-Mab/Bridge Health, Otsuka/Cantargia, JCR/Acumen and more.

Viking Rapidly Advancing Oral And Injectable VK2735 For Obesity

24 Jul 2025

• By Joseph Haas

In its Q2 update, Viking reported that Phase III trials of subcutaneous VK2735 are under way, and that it expects Phase II data for an oral formulation before year’s end.